Invention Grant
US08389477B2 Amylin and amylin agonists for treating psychiatric diseases and disorders
失效
胰岛淀粉样多肽和胰岛淀粉样多肽激动剂用于治疗精神疾病和病症
- Patent Title: Amylin and amylin agonists for treating psychiatric diseases and disorders
- Patent Title (中): 胰岛淀粉样多肽和胰岛淀粉样多肽激动剂用于治疗精神疾病和病症
-
Application No.: US13112290Application Date: 2011-05-20
-
Publication No.: US08389477B2Publication Date: 2013-03-05
- Inventor: Kevin D. Laugero , Michael R. Hanley , Christine M. Mack , David G. Parkes , Andrew A. Young
- Applicant: Kevin D. Laugero , Michael R. Hanley , Christine M. Mack , David G. Parkes , Andrew A. Young
- Applicant Address: US CA San Diego US DE Wilmington
- Assignee: Amylin Pharmaceuticals, LLC,AstraZeneca Pharmaceuticals LP
- Current Assignee: Amylin Pharmaceuticals, LLC,AstraZeneca Pharmaceuticals LP
- Current Assignee Address: US CA San Diego US DE Wilmington
- Main IPC: A01N37/18
- IPC: A01N37/18 ; A61K38/00 ; C07K16/00
Abstract:
Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
Public/Granted literature
- US20110288028A1 AMYLIN AND AMYLIN AGONISTS FOR TREATING PSYCHIATRIC DISEASES AND DISORDERS Public/Granted day:2011-11-24
Information query
IPC分类:
